Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and Safety of Zastaprazan (JP-1366) vs Lansoprazole in Gastric Ulcer
NCT05448001Phase 3Completed
- Sponsor
- Onconic Therapeutics Inc.
- Start
- Sep 2022
- Primary completion
- Jul 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of zastaprazan in gastric ulcer, sponsored by Onconic Therapeutics Inc.. Started Sep 2022; status: completed.
02
Drugs
zastaprazan
03
Conditions
gastric ulcer
Beyond the preview
Go deeper on NCT05448001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05448001.